AIM IP specialist Tekcapital to sell or float all four portfolio companies 'within 2 years'. Watch the full video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7,735.00
Bid: 7,728.00
Ask: 7,730.00
Change: 55.00 (0.72%)
Spread: 2.00 (0.03%)
Open: 7,682.00
High: 7,745.00
Low: 7,673.00
Yest. Close: 7,680.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Sector movers: M&A speculation still in the driver's seat, Big Pharma gains

Mon, 24th Aug 2020 15:23

(Sharecast News) - Mergers and acquisitions speculation continued to drive sector moves at the start of the week - yet again.
This time it was the telecommunications that was in focus.

According to Sky News, BT Group asked bankers at Goldman Sachs to update its defence strategy to fend off potential takeover approaches from industry rivals and buyout firms after the suspension of its dividend sent the shares tumbling to their lowest level in more than a decade.

It was understood that boutique investment bank Robey Warshaw, a long-standing adviser to Vodafone, may also be asked by BT to play a role. Sources told Sky that BT had not yet received a formal approach from any potential suitor.

As of 1503 BST, shares of BT were 5.03% higher with the company's market value again back above the £10bn mark.

AstraZeneca shares were advancing alongside on the back of speculation that the Trump administration might push for fast-track approval of the Covid-19 vaccine under development by Oxford University and the drug giant.

Triggering that speculation, the Financial Times reported on Sunday, that the White House was considering whether to bypass normal US regulatory standards to accelerate that vaccine for use in the States before the presidential elections.

The FT cited three unnamed people briefed on the matter, although a spokesman for the US Health and Human Services department reportedly denied that emergency use approval might be granted before the 3 November elections.

For its part, AstraZeneca added that it had not talked to Washington about a possible EUA for its vaccine.

Shares of AstraZeneca had been rangebound since the end of April in anticipation of clinical trial results that were expected for between early September and early October.

Top performing sectors so far today

Fixed Line Telecommunications 1,324.08 +5.02%

Pharmaceuticals & Biotechnology 18,267.88 +3.05%

Electronic & Electrical Equipment 8,950.20 +2.68%

Oil Equipment, Services & Distribution 4,479.59 +2.66%

Tobacco 26,907.88 +2.66%

Bottom performing sectors so far today

Real Estate Investment & Services 2,441.72 -0.97%

Industrial Transportation 1,944.68 -0.80%

Travel & Leisure 6,462.59 -0.64%

Real Estate Investment Trusts 2,575.44 -0.31%

Alternative Energy 0.00 0.00%

More News

EU's Breton: EU did not renew Astrazeneca COVID-19 vaccine order for after June

PARIS, May 9 (Reuters) - European Internal Market Commissioner Thierry Breton said on Sunday the European Commission did not renew its order for AstraZeneca vaccines against COVID-19 for after June.The European Commission last month launched legal...

Today 11:30

Sri Lanka approves Pfizer COVID vaccine for emergency use

By Waruna KarunatilakeCOLOMBO, May 8 (Reuters) - Sri Lanka on Saturday approved Pfizer's COVID-19 vaccine for emergency use in Sri Lanka, as the island nation battles a third wave of the virus, while suffering a restricted supply of vaccines from ...

8 May 21 09:33

Britain free of coronavirus by August, outgoing vaccine task force chief says -Telegraph

May 7 (Reuters) - The new coronavirus will no longer be circulating in Britain by August, the government's departing vaccine taskforce chief Clive Dix told the Daily Telegraph on Friday."Sometime in August, we will have no circulating virus in th...

8 May 21 00:15

UPDATE 1-AstraZeneca weighs seeking full U.S. approval for COVID shot - WSJ

(Adds background related to AstraZeneca vaccine)May 7 (Reuters) - AstraZeneca Plc may skip asking the U.S. Food and Drug Administration for emergency-use authorization for its COVID-19 vaccine and instead pursue the more time-intensive application...

7 May 21 23:23

UPDATE 2-AstraZeneca weighs seeking full, not emergency, U.S. approval for COVID-19 shot - WSJ

(Adds response from AstraZeneca in paragraphs 3 and 4)May 7 (Reuters) - AstraZeneca Plc may skip asking the U.S. Food and Drug Administration for emergency-use authorization for its COVID-19 vaccine and instead pursue the more time-intensive appli...

7 May 21 23:23

AstraZeneca weighs seeking full U.S. approval for COVID-19 shot -WSJ

May 7 (Reuters) - AstraZeneca Plc may skip asking the U.S. Food and Drug Administration for emergency-use authorization for its COVID-19 vaccine, and instead pursue the more time-intensive application for a full-fledged license to sell the shot, ...

7 May 21 22:52

INSIGHT-How the U.S. locked up vaccine materials other nations urgently need

By Allison Martell and Euan RochaMay 7 (Reuters) - To fight the pandemic at home, the United States gave its own vaccine manufacturers priority access to American-made materials needed to make the shots.As a result, the U.S. government laid claim n...

7 May 21 16:00

WRAPUP 1-Britain, Germany in role reversal on AstraZeneca vaccine risks

* Britain restricts AstraZeneca to people aged over 40* In Germany, all adults free to get AZ shot on doctor's advice* Germany, with eye on summer hols, shortens gap between doses* EU regulator looking at AZ on reports of neurological illnessBy Al...

7 May 21 15:34

UPDATE 1-Vietnam reports first death in patient who received AstraZeneca COVID-19 vaccine

(Adds details and background)By Khanh VuHANOI, May 7 (Reuters) - Vietnam's health ministry on Friday reported its first death in a patient who received AstraZeneca's COVID-19 vaccine shot, as the country is battling a new outbreak.A 35-year-old fe...

7 May 21 15:31

Vietnam reports first death in patient who received AstraZeneca COVID-19 vaccine

HANOI, May 7 (Reuters) - Vietnam's health ministry on Friday reported its first death in a patient who received AstraZeneca's COVID-19 vaccine shot.A 35-year-old female health worker in the southern province of An Giang died on Friday, one day aft...

7 May 21 14:54

UPDATE 1-EU regulator reviews reports of rare nerve disorder after AstraZeneca shot

(Adds details from EMA statement on other vaccines, background)May 7 (Reuters) - Europe's medicines regulator said on Friday it was reviewing reports of a rare nerve-degenerating disorder in people who have received AstraZeneca's COVID-19 vaccine,...

7 May 21 13:15

UPDATE 2-EU reviews reports of rare nerve disorder after AstraZeneca's COVID-19 shot

* EMA reviewing AstraZeneca vaccine for Guillain-Barre syndrome* Rare nerve syndrome also linked some vaccinations in past* EMA also assessing heart inflammation with Pfizer, Moderna shots* Studies into possible links to rare blood clots ongoing (...

7 May 21 13:15

UPDATE 3-EU reviews reports of rare nerve disorder after AstraZeneca's COVID-19 shot

* EMA reviews AstraZeneca shot for Guillain-Barre syndrome* Rare nerve syndrome also linked some vaccinations in past* EMA assessing heart inflammation with Pfizer, Moderna shots* Studies into possible links to rare blood clots ongoing (Adds BioNTe...

7 May 21 13:15

Canada willing to discuss COVID-19 vaccine IP waiver -statement

OTTAWA, May 7 (Reuters) - Canada on Friday said that it was ready to discuss an intellectual property rights (IP) waiver for COVID-19 vaccines while it also recognized the importance of protecting IP and the integral role industry played in devel...

7 May 21 13:00

UPDATE 1-German panel to recommend J&J COVID vaccine for over-60s - Spiegel

(Adds RKI comment, background)BERLIN, May 7 (Reuters) - Germany's vaccine committee, known as STIKO, plans to recommend Johnson & Johnson's COVID-19 vaccine only for people over the age of 60, German magazine Der Spiegel reported on Friday, citing...

7 May 21 12:24

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.